How do GPs communicate the urgent suspected cancer referral pathway to patients? A qualitative study of GP-patient consultations.

Russell J, Boswell L, Ip A, Harris J, Singh H, Meyer A, Giardina TD, Bhuiya A, Whitaker K, Black G. How do GPs communicate the urgent suspected cancer referral pathway to patients? A qualitative study of GP-patient consultations. BJGP open. 2024 Nov 21.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

BACKGROUND: The UK National Institute for Health and Care (NICE) recommends that GPs inform patients referred onto the Urgent Suspected Cancer (USC) pathway about what to expect from the service. However, there is a lack of evidence on patient experience and information needs at the point of referral. It is a challenge for GPs to communicate the reasons for referral and provide reassurance. AIM: This study aimed to examine how GPs communicate a potential cancer diagnosis and USC referral in practice. DESIGN and SETTING: This is a secondary analysis of a dataset of 23 audio-recorded GP-patient consultations, selected from a larger dataset of 200 consultations collected in Surrey and London, UK in 2017-2018. The consultations were selected based on inclusion criteria related to cancer discussions. METHOD: This is a qualitative analysis of video recordings of face to face patient consultations. RESULTS: We found that most GPs informed patients that they might have cancer and engaged in reassurance using personalised risk statements. Some GPs avoided all mention of cancer, using symptom-led language instead. GPs focused on communicating practical rather than support-based information. While most GPs informed patients that they would be seen by a specialist within two weeks, few discussed patients' support needs during the referral period. CONCLUSION: Clear communication about cancer in primary care is promoted in UK policy, and has an important role driving patient investigations attendance. The study highlights the need for further research on communication practices around cancer referral to improve patient understanding and experience. Our recommendations for enhanced communication may improve patient outcomes by optimising routes to diagnosis via primary care.